Balyasny Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $108K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $15.3K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $72K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $323K | Sell |
|
|||||
|
2022
Q3 | $1.67M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.61M | Sell |
|
|||||
|
2021
Q4 | $6.78M | Buy |
|
|||||
|
2021
Q3 | $2.91M | Buy |
|
|||||
|
2021
Q2 | $2.71M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.33M | Sell |
|
|||||
|
2018
Q3 | $8.57M | Sell |
|
|||||
|
2018
Q2 | $14M | Sell |
|
|||||
|
2018
Q1 | $17.3M | Buy |
|
|||||
|
2017
Q4 | $22.9M | Buy |
|
|||||
|
2017
Q3 | $12M | Buy |
|
|||||
|
2017
Q2 | $11.4M | Buy |
|
|||||
|
2017
Q1 | $11.9M | Buy |
|
|||||
|
2016
Q4 | $9.5M | Buy |
|
|||||
|
2016
Q3 | $2.54M | Buy |
|